Skip to main content

Advertisement

Log in

Leadership Roles in Opioid Stewardship and the Treatment of Patients with Opioid Use Disorder Among Medical Toxicologists

  • Original Article
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Background

Despite significant efforts, deaths due to drug overdose remain at near record levels. In efforts combat this crisis, the Joint Commission now requires that accredited hospitals implement safe opioid prescribing practices. Emergency department visits and hospitalizations related to opioid use disorder (OUD) provide an opportunity to initiate evidence-based treatment. However, both situations require the presence of qualified physician leaders and clinicians, which many facilities lack. Medical toxicologists have the expertise needed to fill these voids, but the scope and prevalence of their involvement are unknown. We sought to determine the engagement of medical toxicologists in leading opioid stewardship initiatives and the treatment of patients with OUD.

Methods

Members of the American College of Medical Toxicology (ACMT) were surveyed about their leadership roles in opioid stewardship and clinical practices regarding OUD from March-June 2019. ACMT represents more than 80% of the nation’s board-certified medical toxicologists. The electronic survey utilized branching logic and results are presented descriptively; thus, responses are presented as a percentage of the number of respondents to individual questions rather than the total number of participants.

Results

One hundred and thirty-one out of 382 eligible individuals from at least 76 institutions responded to the survey. A majority (60%) had a DATA 2000 X-waiver, 21% were board-certified in addiction medicine (AM), and an additional 22% were definitely or possibly planning to pursue board certification in AM. Sixteen percent of respondents reported having a formal leadership role to address opioid pain management and stewardship, and 17% had a formal leadership role that specifically addresses clinical treatment for OUD within their institution. Fifty-seven respondents prescribed buprenorphine in emergency medicine practice, 41 as inpatient consultants, and 23 in an outpatient clinic.

Conclusions

Medical toxicologists can serve as leaders to promote safe opioid prescribing practices through both institutional and governmental opioid task forces and opioid stewardship programs. They also provide important addiction-related clinical care to patients with OUD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Redfield R. Opinion: opioids are public health crisis of our time. The Atlanta Journal-Constitution. 2018 June;10.

  2. Hedegaard H, Miniño A, Warner M.. Drug overdose deaths in the United States, 1999–2017. NCHS Data Brief, no 329. Hyattsville, MD: National Center for Health Statistics; 2018.

  3. Murphy S, Xu J, Kochanek K, Arias E. Mortality in the United States, 2017. National Center for Health Statistics: Hyattsville; 2018.

    Google Scholar 

  4. Bernstein L.. U.S. life expectancy declines again, a dismal trend not seen since World War I. The Washington Post. 2018 November 29.

  5. Weiss A, Elixhauser A, Barrett M, Steiner C, Bailey M, O’Malley L. Opioid-related inpatient stays and emergency department visits by state, 2009–2014. Agency for Healthcare Research and Quality: Rockville; 2016.

    Google Scholar 

  6. Sahota PK, Shastry S, Mukamel DB, Murphy L, Yang N, Lotfipour S, et al. Screening emergency department patients for opioid drug use: a qualitative systematic review. Addict Behav. 2018;85:139–46.

    Article  Google Scholar 

  7. The White House. President Donald J. Trump’s initiative to stop opioid abuse and reduce drug supply and demand. 2018. https://www.whitehouse.gov/briefings-statements/president-donald-j-trumps-initiative-stop-opioid-abuse-reduce-drug-supply-demand/ . Accessed August 11 2019.

  8. Weiner SG, Price CN, Atalay AJ, Harry EM, Pabo EA, Patel R, et al. A health system-wide initiative to decrease opioid-related morbidity and mortality. Jt Comm J Qual Patient Saf. 2019;45(1):3–13.

    Article  Google Scholar 

  9. Perrone J, Weiner SG, Nelson LS. Stewarding recovery from the opioid crisis through health system initiatives. West J Emerg Med. 2019;20(2):198–202.

    Article  Google Scholar 

  10. The Joint Commission. Joint Commission enhances pain assessment and management requirements for accredited hospitals. In: Perspectives. 2017. https://www.jointcommission.org/assets/1/18/Joint_Commission_Enhances_Pain_Assessment_and_Management_Requirements_for_Accredited_Hospitals1.PDF . Accessed August 11 2019.

  11. D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–44.

    Article  Google Scholar 

  12. Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, et al. Addiction consultation services–linking hospitalized patients to outpatient addiction treatment. J Subst Abus Treat. 2017;79:1–5.

    Article  Google Scholar 

  13. Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339–42.

    Article  Google Scholar 

  14. O'toole TP, Pollini RA, Ford DE, Bigelow G. The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization. Med Care. 2007:1110–5.

  15. Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–16.

    Article  Google Scholar 

  16. Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2018;68(11):1935–7.

    Article  Google Scholar 

  17. Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, et al. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction. 2016;111(5):892–902.

    Article  Google Scholar 

  18. Clark RE, Baxter JD, Aweh G, O’Connell E, Fisher WH, Barton BA. Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history. J Subst Abus Treat. 2015;57:75–80.

    Article  Google Scholar 

  19. Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, et al. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 2016;111(2):298–308.

    Article  Google Scholar 

  20. Wu L-T, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–27.

    Article  Google Scholar 

  21. Wiegand TJ, Babu KM. Medical toxicology and the crisis of addiction—introduction to the proceedings from the 2015 ACMT Addiction Academy. J Med Toxicol. 2016;12(1):48–9.

    Article  Google Scholar 

  22. Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Subst Abus. 2016;37(4):635–41.

    Article  Google Scholar 

  23. Wakeman SE, Baggett MV, Pham-Kanter G, Campbell EG. Internal medicine residents’ training in substance use disorders: a survey of the quality of instruction and residents’ self-perceived preparedness to diagnose and treat addiction. Subst Abus. 2013;34(4):363–70.

    Article  Google Scholar 

  24. Rapoport AB, Beekmann SE, Polgreen PM, Rowley CF. Injection drug use and infectious disease practice: a national provider survey. Open Forum Infectious Diseases. 2017;4(suppl_1):S340-S.

    Article  Google Scholar 

  25. Laes JR. The integration of medical toxicology and addiction medicine: a new era in patient care. J Med Toxicol. 2016;12(1):79–81.

    Article  CAS  Google Scholar 

  26. Malcho J, Schult R, Wiegand T. Induction of buprenorphine/naloxone for opioid withdrawal in an academic emergency department. Clin Toxicol. 2017;55(7):786.

    Google Scholar 

  27. Fields A, Wiegand T. Buprenorphine treatment of opioid dependence for patients hospitalized with infective endocarditis. J Med Toxicol. 2017;13(1):32.

    Google Scholar 

  28. Wiegand T, Crane P. Buprenorphine induction via telemedicine to emergency department patients. Clin Toxicol. 2018;56(10):982–3.

    Google Scholar 

  29. Dunkley CA, Carpenter JE, Murray BP, Sizemore E, Wheatley M, Morgan BW, et al. Retrospective review of a novel approach to buprenorphine induction in the emergency department. The Journal of Emergency Medicine. 2019;57(2):181–6.

    Article  Google Scholar 

  30. American College of Medical Toxicology. ACMT fact sheet. https://www.acmt.net/ACMT_Fact_Sheet.html . Accessed August 11 2019.

  31. American College of Medical Toxicology. ACMT positions, guidelines, and recommendations. https://www.acmt.net/resources_position.html . Accessed July 10 2019.

  32. Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55–63.

    Article  Google Scholar 

  33. American College of Medical Toxicology. ACMT position statement: buprenorphine administration in the emergency department. 2018. https://www.acmt.net/_Library/Positions/ACMTBuprenorphinePS.pdf . Accessed December 20 2018.

  34. Herring AA, Perrone J, Nelson LS. Managing opioid withdrawal in the emergency department with buprenorphine. Ann Emerg Med. 2019;73(5):481–7.

    Article  Google Scholar 

  35. Weinstein ZM, Wakeman SE, Nolan S. Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems. Med Clin N Am. 2018;102(4):587–601.

    Article  Google Scholar 

  36. Beauchamp GA, Perrone J. Making surveys count: enhancing the rigor of survey-based research in medical toxicology. J Med Toxicol. 2016;12(4):329–31.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph E. Carpenter.

Ethics declarations

Conflict of Interest

None.

Disclaimer

The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of the US Air Force Office of the Surgeon General, the Department of the Air Force, the Department of Defense, or the US Government.

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(PDF 128 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carpenter, J.E., Murray, B.P., Mazer-Amirshahi, M. et al. Leadership Roles in Opioid Stewardship and the Treatment of Patients with Opioid Use Disorder Among Medical Toxicologists. J. Med. Toxicol. 16, 204–211 (2020). https://doi.org/10.1007/s13181-019-00752-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-019-00752-9

Keywords

Navigation